CRISPR-Cas9 gene editing of inhibitory receptor signaling pathways improves CAR T cell activity against glioblastoma

被引：0

作者：

Sanber, Khaled ^{[1
]}

Nawas, Zeid ^{[1
]}

Salsman, Vita ^{[1
]}

Gad, Ahmed ^{[1
]}

Matthew, Pretty Rose ^{[1
]}

Landi, Daniel ^{[1
]}

Lee, Ciaran ^{[2
]}

Sengal, Amel ^{[1
]}

Chakraborty, Rikhia ^{[1
]}

Joseph, Sujith ^{[1
]}

Nabil, Ahmed ^{[1
]}

Hegde, Meenakshi ^{[1
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Rice Univ, Houston, TX USA

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-2173

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2173

引用

页数：2

共 50 条

[11] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Lakshmi, Dhanya N.
INDIAN PEDIATRICS, 2022, 59 (06) : 458 - 458
[12] Gene Editing of Human Hepatocytes by CRISPR-Cas9
Zhang, Qingshuo
Tiyaboonchai, Amita
Balaji, Niveditha
Naugler, Willscott
Grompe, Markus
MOLECULAR THERAPY, 2018, 26 (05) : 367 - 367
[13] CRISPR-cas9 Gene Editing for Cystic Fibrosis
Xia, Emily
MOLECULAR THERAPY, 2019, 27 (04) : 196 - 196
[14] CRISPR-Cas9 gene editing and human diseases
Jinka, Chaitra
Sainath, Chithirala
Babu, Shyamaladevi
Chakravarthi, Chennupati Ashok
Prasanna, Muppidi Lakshmi
Krishnan, Madhan
Sekar, Gayathri
Chinnaiyan, Mayilvanan
Kumari, Andugula Swapna
BIOINFORMATION, 2022, 18 (11) : 1081 - 1086
[15] CRISPR-Cas9 gene editing for patients with haemoglobinopathies
不详
LANCET HAEMATOLOGY, 2019, 6 (09): : E438 - E438
[16] Improving CAR-T cell immunotherapy with CRISPR/Cas9 gene editing
Sarac, Andrea
Ogorelec, Karen Butina
Pohar, Jelka
Horvat, Simon
Smole, Anze
EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 746 - 746
[17] Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
Al-Sammarraie, Nadia
Ray, Swapan K.
CELLS, 2021, 10 (09)
[18] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia REPLY
Frangoul, Haydar
Ho, Tony W.
Corbacioglu, Selim
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23):
[19] Reactive oxygen signaling molecule inducible regulation of CRISPR-Cas9 gene editing
Zhao, Jizhong
Hu, Hongmei
Zhou, Hongling
Zhang, Jingwen
Wang, Li
Wang, Rui
CELL BIOLOGY AND TOXICOLOGY, 2023, 39 (05) : 2421 - 2429
[20] Reactive oxygen signaling molecule inducible regulation of CRISPR-Cas9 gene editing
Jizhong Zhao
Hongmei Hu
Hongling Zhou
Jingwen Zhang
Li Wang
Rui Wang
Cell Biology and Toxicology, 2023, 39 (5) : 2421 - 2429

← 1 2 3 4 5 →